InvestorsHub Logo
Followers 64
Posts 4318
Boards Moderated 0
Alias Born 05/25/2021

Re: exwannabe post# 704293

Sunday, 07/07/2024 11:51:32 AM

Sunday, July 07, 2024 11:51:32 AM

Post# of 710728
It doesn't matter if poly-iclc was approved or not. Data from hundreds of patients from the Compassionate use program will warrant the approval of DCVax-L in combination with Poly-ICLC based on RWE/RWD. There must be a reason the filing package is 1.7m pages. Keytruda should be adopted as off-label drug based on the combo trial.

Time is limited. Find another angle.
BTW, no one expects your farwell address.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News